Latest News and Press Releases

Alumis Stockholders Approve Merger with ACELYRIN

NEWARK, Del, March 23, 2025 (GLOBE NEWSWIRE) -- The global autoimmune disease therapeutics market is set to experience significant expansion, with projections indicating an increase from...

ESK-001 demonstrated robust clinical responses and was well tolerated over 52 weeks in a Phase 2 clinical trial, presented in a late-breaker at AAD 2025

Wilmington, Delaware, Transparency Market Research Inc. – , Feb. 05, 2025 (GLOBE NEWSWIRE) -- The global on-body drug delivery devices market is revolutionizing patient care by enabling painless,...

Amarna Therapeutics Partners with NorthX Biologics to Advance Nimvec™ AM510 Gene Therapy Development Leiden, The Netherlands, 3 December 2024 - Amarna Therapeutics, (“Amarna” or “the Company”), a...

Wilmington, Delaware, United States, Transparency Market Research Inc. -, Nov. 04, 2024 (GLOBE NEWSWIRE) -- The global multiplex assays market (멀티플렉스 분석 시장) is estimated to be valued at US$ 5.9...

                Treating diabetes patients earlier with PTG-007 could provide functional cureRecruitment will go ahead after European Medicines Agency approvalCompany has 12 years’ worth of safety...

Selbyville, Delaware, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Tumor Necrosis Factor Inhibitor Drugs Market size valued at USD 41.3 billion in 2023 and is projected to grow at a CAGR of 2.2% from...

Over a decade of clinical data, experience and know-how with lead polyclonal Treg cell therapy PTG-007 in type-1 diabetes will accelerate CAR-Treg candidate developmentNew CAR-Treg cell therapy...

China’s National Intellectual Property Administration has issued notification to grant patent to PolTREG Chinese patent covers intrathecal administration of PolTREG’s PTG-007 Treg cell therapy to...